2016/03/17 - Quantum Genomics raises €5.54m via private placement in the United States and launches a capital increase amounting to €2.94m

Quantum Genomics (Alternext – FR0011648971 – ALQGC), a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, announces the completion of a capital increase via private placement in the amount of €5.54 million by the issuance of 923,644 shares with redeemable equity warrants at €6.00 per share.

Download Press Release